Dutch FoodTech Scale-up Revyve Raises €24M In Series B Round

The round was co-led by ABN AMRO Sustainable Impact Fund and Invest-NL, with regional support from Brabantse Ontwikkelings Maatschappij (BOM) and strategic backing from Lallemand Bio-Ingredients’ Swiss arm Danstar Ferment and Grey Silo Ventures (CVC of Cereal Docks Group). Existing investors Oost NL and Royal Cosun also increased their stakes.

“Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction,” said Cedric Verstraeten, CEO of Revyve.

He adds: “This funding round marks a tipping point for us: allowing us to modularly scale production and branch out to more food categories and serve our sustainable solutions to larger customers worldwide.”

Read Also - Monsana Secures €500K To Accelerate Patient Enrollment In Clinical Trials

Founded in 2021, Revyve is a purpose-driven FoodTech startup aiming to create a more sustainable food system. Spun out from Wageningen University & Research (WUR), the company’s scientists discovered yeast can replicate the functional properties of eggs.

Revyve’s ingredients deliver authentic textures, enabling the replacement of animal proteins and cleaner, simpler product labels.

“We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients. Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers.

“We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader. We look forward to supporting their journey,” said Hanna Zwietering, ABN AMRO SIF Senior Investment Manager.

Lisette Kersting-van der Boog, Senior Investment Manager of Invest-NL adds: “With their functional egg-replacement ingredients, Revyve can play a major role in accelerating the global protein transition and fostering circular solutions that reduce pressure on land, water and animals. We are proud to invest in this Dutch company, which strengthens the country’s innovative power with a pioneering technology that has the potential to transform food production worldwide.”

In 2024, Revyve launched its first-of-a-kind production facility in Dinteloord, the Netherlands. Already operating at full capacity for multiple clients, the site has demonstrated the company’s capability to produce and sell at industrial scale. The new funding will boost output to over 1,600 tons annually, securing a reliable global supply.

Verstraeten adds: “Strong regional support from both the Wageningen and Brabant ecosystems has enabled us to scale to industrial levels in record time. With a stellar team and strong investor backing, we have an incredibly solid foundation for global expansion.”

With industrial-scale production underway, Revyve is already supplying customers in Europe, the UK, the USA, Canada, Mexico, and Australia.

“Revyve’s plans align seamlessly with our mission to position Brabant as the Scale-Up Plant of Europe. Their breakthrough technology not only contributes to a more sustainable food system but also exemplifies the kind of bold innovation we aim to foster in the region. We’re proud to support Revyve in scaling their impact from Brabant to the world,” added Ingrid Nieweg, Investment Manager at BOM.

About Revyve

Founded in 2021 Revyve creates simple, sustainable microbial ingredients from circular biomass like brewer’s yeast. Highly functional, these ingredients can replace E-numbers and animal products, enhancing the taste and texture of alternative proteins while driving a more sustainable and innovative future for food.